Skip to content

Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort

Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort (BioBase)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05458661
Acronym
BioBase
Enrollment
100
Registered
2022-07-14
Start date
2022-08-31
Completion date
2023-03-31
Last updated
2022-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Lens Implant, Cataract, Corneal Astigmatism, Corneal Defect, Corneal Deformity, Lens Opacities

Brief summary

The planned clinical investigation will be conducted to acquire raw data for the development of the algorithm. The data acquisition is intended to obtain first impressions of the potential performance of the changed hardware and software components and to confirm the safety profile assessed by risk analysis.

Interventions

DEVICEClinical Prototype BioBase (SN 07 and SN 08)

Scheimpflug- or OCT based corneal tomographers with the ability to measure anterior and posterior corneal curvature maps \>6mm diameter and corneal pachymetry maps \>6mm.

Sponsors

Carl Zeiss Meditec AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

all suitable/eligible subjects will undergo a series of biometry measurements

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female 21 years of age and older * Able and willing to make the required study visit * Able and willing to provide consent and follow study instructions * Patients must have understood and signed the informed consent

Exclusion criteria

* Any performed contact measurements or examinations in which the eye is touched on the same day prior to the investigation measurement * Physical inability to be positioned at the study devices (e.g. torticollis, head tremor, injuries at forehead or chin, etc.) * Principal Investigator's determination that the subject is not suitable due to other medical condition (reasons to be listed on eCRF) * Known Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Data collection for algorithm development - Cornea to retina Scanday 1\- Cornea to retina Scan (all axial measurements) The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Data collection for algorithm development - Corneal topographyday 1\- Corneal topography (raw data and images) including keratometry The data will then be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Data collection for algorithm development - - Anterior-segment OCT dataday 1\- Anterior-segment OCT data The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Data collection for algorithm development - Extended retina-scanday1\- Extended retina-scan The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Data collection for algorithm development - Reference pictures for markerless alignment of toric IOL (sclera images)day 1\- Reference pictures for markerless alignment of toric IOL (sclera images) The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Data collection for algorithm development - White-to-white determinationday 1\- White-to-white determination The data will then be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Data collection for algorithm development - IOL Imaging picturesday 1\- IOL Imaging pictures The data will then be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.
Affected measurements - OCT measurementsday 1It will be investigated, whether the measurements with the study prototype device are affected by the base movement. \- OCT measurements This outcome will be investigated by comparing the raw data of the study prototype device with the data measured with the marketed IOLMaster 700 and Pentacam / MS-39 devices. Non-optimal positioning and movement could possibly cause blurred images that would prevent a detailed analysis
Affected measurements - Keratometry and Topography measurementsday 1It will be investigated, whether the measurements with the study prototype device are affected by the base movement. \- Keratometry and Topography measurements This outcome will be investigated by comparing the raw data of the study prototype device with the data measured with the marketed IOLMaster 700 and Pentacam / MS-39 devices. Non-optimal positioning and movement could possibly cause blurred images that would prevent a detailed analysis
Affected measurements - - WTW measurementsday 1It will be investigated, whether the measurements with the study prototype device are affected by the base movement. \- WTW measurements This outcome will be investigated by comparing the raw data of the study prototype device with the data measured with the marketed IOLMaster 700 and Pentacam / MS-39 devices. Non-optimal positioning and movement could possibly cause blurred images that would prevent a detailed analysis

Contacts

Primary ContactMonika Peter, M.Sc.
monika.peter@zeiss.com+49 3641 22016

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026